In the GLP1-RA exposed group, concomitant or subsequent use of antidiabetic medications was reported in 44 (26.2%) cases, meaning in almost all women with diabetes (n=46) and of these, the use of more than one (non-GLP1-RA) antidiabetic medication was reported in 19 cases. This evidence concerns the gene GCG and diabetes mellitus.